Table 2.
Pediatric populations at increased risk for vitamin D deficiency
| • Exclusively breastfed infants without vitamin D prophylaxis | |
| • Infants, children, and adolescents with: | |
| • Malabsorption or maldigestion disorders (e.g., celiac disease, Crohn’s disease, cystic fibrosis) | |
| • Chronic inflammatory diseases (e.g., inflammatory bowel disease) | |
| • Chronic kidney disease | |
| • Chronic liver disease | |
| • On permanent medication with substances that affect calcium or vitamin D metabolism (e.g., antiepileptic drugs, antiviral medication, fungicides, or high dose glucocorticoid therapy which inhibits intestinal calcium absorption and stimulates tubular calcium excretion) | |
| • With very low sun exposure, for example, chronically immobilized children and adolescents | |
| • With a migrant background (through the influence of pigmentation, nutrition, and sun exposure) |